2009
DOI: 10.1016/j.fertnstert.2008.04.014
|View full text |Cite
|
Sign up to set email alerts
|

Obstetric outcomes following vitrification of in vitro and in vivo matured oocytes

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
127
1
10

Year Published

2010
2010
2023
2023

Publication Types

Select...
4
3
1

Relationship

0
8

Authors

Journals

citations
Cited by 196 publications
(139 citation statements)
references
References 49 publications
(48 reference statements)
1
127
1
10
Order By: Relevance
“…Higher IVM rate and lower incidence of aneuploidy in the group received amifostine prior to CP, indicated using IVM of oocytes is possible following utilization of protective drugs prior to chemotherapy. IVM has been listed as one of options to improve fertility preservation in cancer patients [25]. Cryopreservation of embryos has been recommended for fertility preservation before chemotherapy for breast cancer.…”
Section: Discussionmentioning
confidence: 99%
See 2 more Smart Citations
“…Higher IVM rate and lower incidence of aneuploidy in the group received amifostine prior to CP, indicated using IVM of oocytes is possible following utilization of protective drugs prior to chemotherapy. IVM has been listed as one of options to improve fertility preservation in cancer patients [25]. Cryopreservation of embryos has been recommended for fertility preservation before chemotherapy for breast cancer.…”
Section: Discussionmentioning
confidence: 99%
“…Ovarian tissue transplantation has been one of techniques for fertility preservation. However the risk of reintroducing cancer from stored ovarian tissue must be always considered [25]. Therefore IVM following chemotherapy and application of protective drugs such as amifostine is maybe a promising technique for fertility preservation in hormone sensitive disease such as endometrial [38] and ovarian cancers [39].…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Caution must therefore be exercised in extrapolating the data for both efficiency and safety to the young cancer patient population 46 . Variations on ivm techniques applied to cancer patients (for example, with respect to the degree of ovarian stimulation) make outcomes and success rates even more challenging to elucidate.…”
Section: Ivmmentioning
confidence: 99%
“…2. These trees expand upon other excellent decision-making resources that provide roadmaps for navigating patients with cancer [20,21]. Fig.…”
Section: The Decision Tree: a Provider-facing Resourcementioning
confidence: 99%